ALFA Finder
17:02 IST
BSE
Earnings Call
Gland Pharma Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹18,336 Mn (+23% YoY), PAT ₹2,908 Mn (+58%), adj. EBITDA margin 27%. US CDMO and launches lead; India and RoW weak.
Gland Pharma Ltd
Gland Pharma Ltd news stories on ALFA NewsRead the news →- Share price
- ₹3,263.90
- Market cap
- ₹53,858 Cr
- Revenue (annual)
- ₹6,431 Cr
- Net profit (annual)
- ₹1,027 Cr
- P/E (TTM)
- 43.6×Sector 43.8×
- Promoter holding
- 45.75%-6.02% QoQ
- FII holding
- 10.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Results Update 1Regulatory Approval 1Management Change 1Financial Results 1Earnings Call 1Business Update 1Board Meeting Date 1Annual General Meeting 1
Time
1 announcement with these filters